Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:329-334

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rhaleb, N.-E.
Right arrow Articles by Carretero, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rhaleb, N.-E.
Right arrow Articles by Carretero, O. A.

(Hypertension. 1999;33:329-334.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Effect of ACE Inhibitor on DOCA-Salt– and Aortic Coarctation–Induced Hypertension in Mice

Do Kinin B2 Receptors Play a Role?

Nour-Eddine Rhaleb; Hongmei Peng; Marcos E. Alfie; Edward G. Shesely; Oscar A. Carretero

From the Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Mich.

Correspondence to Nour-Eddine Rhaleb, PhD, Room 7015 Education & Research Building, Henry Ford Hospital, Hypertension and Vascular Research Division, 2799 West Grand Blvd, Detroit, MI 48202-2689. E-mail nrhaleb1{at}hfhs.org

Abstract—Kinins have been shown to play an important role in the cardioprotective effect of ACE inhibitors (ACEi) during heart failure and ischemia-reperfusion. However, it is controversial as to whether kinins oppose the hypertensinogenic effect of deoxycorticosterone acetate plus salt (DOCA-salt) or aortic coarctation and whether they mediate both chronic antihypertensive and cardiac antihypertrophic effects of ACEi in hypertension. Using normal 129/SvEvTac mice and mice lacking the bradykinin B2 receptor gene (B2-KO), we investigated whether (1) the hypertensinogenic effect of DOCA-salt or aortic coarctation is enhanced in B2-KO mice and (2) the chronic antihypertensive and antihypertrophic effects of an ACEi (ramipril, 4 mg · kg-1 · d-1) are mediated by B2 receptors in aortic coarctation (6 weeks)– and DOCA-salt (4 weeks)–induced hypertension. Before surgery, there was no difference between 129/SvEvTac and B2-KO mice in terms of blood pressure and heart weight, suggesting that kinins are not essential to maintaining normal blood pressure. DOCA-salt (volume expansion) or aortic coarctation (renin-dependent) induced similar hypertension and left ventricular hypertrophy (LVH) in 129/SvEvTac and B2-KO mice, suggesting that kinins do not play an essential role in the development of DOCA-salt– or aortic coarctation–induced hypertension. We found that B2 receptors mediate only the early (1 week) but not the late phase (4 weeks) of the chronic hypotensive effect of ACEi in DOCA-salt hypertension. On the other hand, chronic ACE inhibition prevented the development of hypertension and LVH in both 129/SvEvTac and B2-KO mice given DOCA-salt or subjected to aortic coarctation, suggesting that kinins do not participate in the chronic antihypertensive and antihypertrophic effects of ACEi in these 2 models of hypertension. Thus, in mice, kinins acting via B2 receptors do not participate in (1) maintenance of normal basal blood pressure, (2) establishment and maintenance of hypertension induced by DOCA-salt or aortic coarctation, and (3) chronic antihypertensive and cardiac antihypertrophic effects of ACEi in DOCA-salt and aortic coarctation hypertension.


Key Words: receptors, bradykinin • angiotensin-converting enzyme inhibitors • deoxycorticosterone • coarctation, aortic • blood pressure • gene regulation




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
P. Muller, A. Kazakov, P. Jagoda, A. Semenov, M. Bohm, and U. Laufs
ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload
Cardiovasc Res, July 1, 2009; 83(1): 106 - 114.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Cayla, M. Todiras, R. Iliescu, V. V. Saul, V. Gross, B. Pilz, G. Chai, V. F. Merino, J. B. Pesquero, O. C. Baltatu, et al.
Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension
FASEB J, June 1, 2007; 21(8): 1689 - 1698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. J. Barrick, M. Rojas, R. Schoonhoven, S. S. Smyth, and D. W. Threadgill
Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2119 - H2130.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Sun, O. A. Carretero, J. Xu, N.-E. Rhaleb, F. Wang, C. Lin, J. J. Yang, P. J. Pagano, and X.-P. Yang
Lack of Inducible NO Synthase Reduces Oxidative Stress and Enhances Cardiac Response to Isoproterenol in Mice With Deoxycorticosterone Acetate-Salt Hypertension
Hypertension, December 1, 2005; 46(6): 1355 - 1361.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. J. Murphey, W. K. Eccles, G. H. Williams, and N. J. Brown
Loss of Sodium Modulation of Plasma Kinins in Human Hypertension
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1046 - 1052.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Hartner, N. Cordasic, B. Klanke, R. Veelken, and K. F. Hilgers
Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice
Nephrol. Dial. Transplant., October 1, 2003; 18(10): 1999 - 2004.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. Varagic, D. Susic, M. Slama, and E. D. Frohlich
Omapatrilat Induces Profound Renal Vasodilation but Does Not Affect Coronary Hemodynamics
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 167 - 174.
[Abstract] [PDF]


Home page
HypertensionHome page
F. Trabold, S. Pons, A. A. Hagege, M. Bloch-Faure, F. Alhenc-Gelas, J.-F. Giudicelli, C. Richer-Giudicelli, and P. Meneton
Cardiovascular Phenotypes of Kinin B2 Receptor- and Tissue Kallikrein-Deficient Mice
Hypertension, July 1, 2002; 40(1): 90 - 95.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Q. Wang, E. Hummler, J. Nussberger, S. Clement, G. Gabbiani, H. R. Brunner, and M. Burnier
Blood Pressure, Cardiac, and Renal Responses to Salt and Deoxycorticosterone Acetate in Mice: Role of Renin Genes
J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1509 - 1516.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Duka, S. Shenouda, C. Johns, E. Kintsurashvili, I. Gavras, and H. Gavras
Role of the B2 Receptor of Bradykinin in Insulin Sensitivity
Hypertension, December 1, 2001; 38(6): 1355 - 1360.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Majima, M. Katori, N.-E. Rhaleb, X.-P. Yang, M. Nanba, E. G. Shesely, O. A. Carretero, P. Madeddu, N.-E. Rhaleb, X.-P. Yang, et al.
Effect of Chronic Blockade of the Kallikrein-Kinin System on the Development of Hypertension in Rats * Response * Role of Kinins in Blood Pressure Regulation: Reality or Fiction * Response
Hypertension, October 1, 2001; 38 (4): e21 - e23.
[Full Text] [PDF]


Home page
HypertensionHome page
H. Peng, O. A. Carretero, M. E. Alfie, J. A. Masura, and N.-E. Rhaleb
Effects of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Type 1 Receptor Antagonist in Deoxycorticosterone Acetate-Salt Hypertensive Mice Lacking Ren-2 Gene
Hypertension, March 1, 2001; 37(3): 974 - 980.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Duka, E. Kintsurashvili, I. Gavras, C. Johns, M. Bresnahan, and H. Gavras
Vasoactive Potential of the B1 Bradykinin Receptor in Normotension and Hypertension
Circ. Res., February 16, 2001; 88(3): 275 - 281.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N.-E. Rhaleb, X.-P. Yang, M. Nanba, E. G. Shesely, and O. A. Carretero
Effect of Chronic Blockade of the Kallikrein-Kinin System on the Development of Hypertension in Rats
Hypertension, January 1, 2001; 37(1): 121 - 128.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Madeddu, C. Emanueli, N.-E. Rhaleb, E. G. Shesely, and O. A. Carretero
Can Knockout Mice Help Dissect Relevant Genes in Hypertension? Evidence and Confounding Factors • Response
Hypertension, December 1, 1999; 34 (6): e14 - e15.
[Full Text] [PDF]


Home page
CirculationHome page
V. Gaussin and M. D. Schneider
Surviving Infarction One Gene at a Time : Decreased Remodeling and Mortality in Engineered Mice Lacking the Angiotensin II Type 1A Receptor
Circulation, November 16, 1999; 100(20): 2043 - 2044.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-P. Yang, Y.-H. Liu, N.-E. Rhaleb, N. Kurihara, H. E. Kim, and O. A. Carretero
Echocardiographic assessment of cardiac function in conscious and anesthetized mice
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1967 - H1974.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X.-P. Yang, Y.-H. Liu, D. Mehta, M. A. Cavasin, E. Shesely, J. Xu, F. Liu, and O. A. Carretero
Diminished Cardioprotective Response to Inhibition of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor in B2 Kinin Receptor Gene Knockout Mice
Circ. Res., May 25, 2001; 88(10): 1072 - 1079.
[Abstract] [Full Text] [PDF]